drugset / Trial / NCT00984659

Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease

NCT00984659

Phase 4 Completed 366 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindOther

Summary

The purpose of this study is to evaluate a new questionnaire to capture the patient experience of COPD. The information collected will be used to validate the Shortness of Breath with Daily Activities Questionnaire.

Timeline

Start
2009-10-29
Primary completion
2010-07-01
Completion
2010-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 250 ug
Subject Salmeterol Other / unclassified 50 ug